» Articles » PMID: 8606070

Roles of Autolysin and Pneumolysin in Middle Ear Inflammation Caused by a Type 3 Streptococcus Pneumoniae Strain in the Chinchilla Otitis Media Model

Overview
Journal Infect Immun
Date 1996 Apr 1
PMID 8606070
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococcus pneumoniae cell wall and pneumolysin are important contributors to pneumococcal pathogenicity in some animal models. To further explore these factors in middle ear inflammation caused by pneumococci, penicillin-induced inflammatory acceleration was studied by using three closely related pneumococcal strains: a wild-type 3 strain (WT3), its pneumolysin-negative derivative (P-1), and into autolysin-negative derivative (A-1). Both middle ears of chinchillas were inoculated with one of the three pneumococcal strains. During the first 12 h, all three strains grew in vivo at the same rate, and all three strains induced similar inflammatory cell responses in middle ear fluid (MEF). Procaine penicillin G was given as 12 h to one-half of the animals in each group, and all treated chinchillas had sterile MEF at 24 h. Penicillin significantly accelerated MEF inflammatory cell influx into WT3-and P-1-infected ears at 18 and 24 h in comparison with the rate for penicillin-treated A-1-infected ears. Inflammatory cell influx was slightly, but not significantly, greater after treatment of WT3 infection than after treatment of P-1 infection. Interleukin (IL)-1beta and IL-6, but not IL-8, concentrations in MEF at 24 h reflected the penicillin effect on MEF inflammatory cells; however, differences between treatment groups were not significant. Results suggest that pneumococcal otitis media pathogenesis is triggered principally by the inflammatory effects of intact and lytic cell wall products in the middle ear, with at most a modes additional pneumolysin effect. Investigation strategies that limit the release of these products or neutralize them warrant further investigation.

Citing Articles

Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid.

Thanawastien A, Joyce K, Cartee R, Haines L, Pelton S, Tweten R Vaccine. 2020; 39(11):1652-1660.

PMID: 32532546 PMC: 8237519. DOI: 10.1016/j.vaccine.2020.04.064.


Anatomical site-specific contributions of pneumococcal virulence determinants.

Shenoy A, Orihuela C Pneumonia (Nathan). 2016; 8.

PMID: 27635368 PMC: 5021320. DOI: 10.1186/s41479-016-0007-9.


Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media.

Keller L, Bradshaw J, Pipkins H, McDaniel L Front Cell Infect Microbiol. 2016; 6:55.

PMID: 27242973 PMC: 4870244. DOI: 10.3389/fcimb.2016.00055.


The pneumococcus: epidemiology, microbiology, and pathogenesis.

Henriques-Normark B, Tuomanen E Cold Spring Harb Perspect Med. 2013; 3(7).

PMID: 23818515 PMC: 3685878. DOI: 10.1101/cshperspect.a010215.


Interaction of phase variation, host and pressure/gas composition: pneumococcal gene expression of PsaA, SpxB, Ply and LytA in simulated middle ear environments.

Li-Korotky H, Lo C, Zeng F, Lo D, Banks J Int J Pediatr Otorhinolaryngol. 2009; 73(10):1417-22.

PMID: 19682756 PMC: 2891361. DOI: 10.1016/j.ijporl.2009.07.007.


References
1.
Berry A, Paton J, HANSMAN D . Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3. Microb Pathog. 1992; 12(2):87-93. DOI: 10.1016/0882-4010(92)90111-z. View

2.
Lock R, HANSMAN D, Paton J . Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae. Microb Pathog. 1992; 12(2):137-43. DOI: 10.1016/0882-4010(92)90116-6. View

3.
Yellon R, Leonard G, Marucha P, Sidman J, Carpenter R, Burleson J . Demonstration of interleukin 6 in middle ear effusions. Arch Otolaryngol Head Neck Surg. 1992; 118(7):745-8. DOI: 10.1001/archotol.1992.01880070075014. View

4.
BLUESTONE C, Stephenson J, Martin L . Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992; 11(8 Suppl):S7-11. DOI: 10.1097/00006454-199208001-00002. View

5.
Himi T, Suzuki T, Kodama H, TAKEZAWA H, KATAURA A . Immunologic characteristics of cytokines in otitis media with effusion. Ann Otol Rhinol Laryngol Suppl. 1992; 157:21-5. DOI: 10.1177/0003489492101s1006. View